BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

0.8024

-0.0426 (-5.04%)

At close: Jul 29, 2026, 4:00 PM EDT

0.8700

+0.0676 (8.42%)

After-hours: Jul 29, 2026, 7:54 PM EDT

BioXcel Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	25	36	19	88	605	569
Market Cap Growth	125.24%	92.59%	-78.99%	-85.40%	6.29%	-49.57%
Enterprise Value	107.89	116.56	91.27	124.11	504.71	336.97
Last Close Price	0.80	1.60	5.98	47.20	343.68	325.28

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	36.44	55.65	8.19	63.98	1612.26	-
PB Ratio	-	-0.37	-0.20	-1.56	7.87	2.57
P/TBV Ratio	-	-	-	-	7.84	2.42

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	158.65	181.56	40.28	89.94	1345.89	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-0.74	-0.89	-1.10	-1.79	1.22	0.00
Net Debt / Equity Ratio	-0.79	-0.85	-0.78	-0.63	-1.30	-1.05
Net Debt / EBITDA Ratio	-1.65	-1.61	-1.09	-0.21	0.63	2.17
Net Debt / FCF Ratio	-1.45	-1.40	-1.01	-0.23	0.74	2.81
Asset Turnover	0.01	0.02	0.04	0.01	0.00	0
Inventory Turnover	0.71	0.23	1.61	0.63	0.02	-
Quick Ratio	0.32	0.54	1.35	2.39	5.90	13.98
Current Ratio	0.62	0.83	1.68	2.65	6.17	14.21
Return on Equity (ROE)	74.96%	74.14%	79.67%	-1766.94%	-111.08%	-49.93%
Return on Assets (ROA)	-128.16%	-121.22%	-120.04%	-122.90%	-71.70%	-46.56%
Return on Invested Capital (ROIC)	-212.05%	-386.58%	-5373.15%	-7560.83%	-5689.42%	-3889.96%
Return on Capital Employed (ROCE)	337.47%	-1422.44%	-215.05%	-156.60%	-80.68%	-49.64%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-417.97%	-381.58%	-39.21%	-4.00%	-6.23%	-21.63%
Total Shareholder Return	-417.97%	-381.58%	-39.21%	-4.00%	-6.23%	-21.63%

SEC Filings: 10-K · 10-Q